Michael Mark, Scharf Rebecca, Letzkus Lisa, Vergales Jeffrey
Pediatric Cardiology, University of Virginia, Charlottesville, Va, USA.
Division of Pediatric Cardiology, Newark Beth Israel Medical Center, Newark, NJ, USA.
Congenit Heart Dis. 2016 Mar-Apr;11(2):183-8. doi: 10.1111/chd.12333. Epub 2016 Feb 22.
We hypothesize that neurodevelopmental surveillance of targeted patients with congenital heart disease during the admission for their cardiac surgery would improve neurodevelopmental assessment and outpatient follow-up rates.
All patients under 12 months of age who were operated on between October 2013 and October 2014 and were considered at risk for neurodevelopmental delay in accordance with the 2012 American Heart Association Scientific Statement were included. A protocol was implemented to increase surveillance of targeted patients during the hospitalization for their cardiac surgery. A historical control cohort was used from a 6-month period that preceded initiation of the program from July 2012 to December 2012. Univariate analysis assessed the effects of patient demographics, anatomy, postoperative course, and distance from clinic on inpatient screening and follow-up to evaluate areas for future improvement.
Neurodevelopmental surveillance in the post-protocol period increased from 21% to 82% (P < .001) as did compliance rates for outpatient follow-up from 38% to 52% (P < .001). Patients receiving consultation were younger (median 1.2 months range 0.3-3.1 vs. 4.0 range 1.2-5.5, P = .002), had a longer intensive care unit duration (median 8 days range 4-13 vs. 4 range 3-8, P = .044), and a longer total hospital duration (median 14 days range 8-25 vs. 8 range 6-16, P = .023). The presence of single ventricle anatomy was associated with a lower follow-up rate at 29% than those with biventricular hearts at 64% (P = .009). Distance from the clinic did not have an effect on follow-up (P = .39).
The protocol described increased neurodevelopmental surveillance of high risk patients. Individuals that were younger and in the hospital longer were more likely to be successfully seen and comply with outpatient follow-up than those not receiving inpatient risk assessment. Patients with single ventricle anatomy may benefit from a modified follow-up schedule to improve compliance rates. Travel distance has no effect on likelihood of outpatient cardiac neurodevelopmental follow-up.
我们假设,对患有先天性心脏病的目标患者在心脏手术住院期间进行神经发育监测,将改善神经发育评估及门诊随访率。
纳入2013年10月至2014年10月期间接受手术且根据2012年美国心脏协会科学声明被认为有神经发育延迟风险的所有12个月以下患者。实施了一项方案,以加强对目标患者心脏手术住院期间的监测。使用了一个历史对照队列,该队列来自2012年7月至2012年12月该方案启动前的6个月期间。单因素分析评估了患者人口统计学、解剖结构、术后病程及距诊所距离对住院筛查和随访的影响,以评估未来可改进的方面。
方案实施后神经发育监测从21%增至82%(P <.001),门诊随访依从率也从38%增至52%(P <.001)。接受会诊的患者年龄更小(中位年龄1.2个月,范围0.3 - 3.1岁,对比4.0岁,范围1.2 - 5.5岁,P =.002),重症监护病房时长更长(中位8天,范围4 - 13天,对比4天,范围3 - 8天,P =.044),总住院时长更长(中位14天,范围8 - 25天,对比8天,范围6 - 16天,P =.023)。单心室解剖结构患者的随访率为29%,低于双心室心脏患者的64%(P =.009)。距诊所距离对随访无影响(P =.39)。
所描述的方案增加了对高危患者的神经发育监测。与未接受住院风险评估的患者相比,年龄更小且住院时间更长的个体更有可能成功接受检查并遵守门诊随访。单心室解剖结构的患者可能受益于调整后的随访计划,以提高依从率。出行距离对门诊心脏神经发育随访的可能性无影响。